Rates of exacerbations were not as remarkable as demonstrated in the Calverley studies, which were numerically lower in the roflumilast arm than the comparator arm but did not reach statistical significance.
1
—
—
Rates of exacerbations were not as remarkable as demonstrated in the Calverley studies, which were numerically lower in the roflumilast arm than the comparator arm but did not reach statistical significance.